Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma

BACKGROUND: Positron emission tomography (PET) with F-18-labeled fluorodeoxyglucose (FDG) provides remarkable accuracy in detection, treatment monitoring and follow-up of systemic malignant lymphoma. Its value in the management of patients with primary central nervous system lymphoma (PCNSL) is less...

Descripción completa

Detalles Bibliográficos
Autores principales: Maza, Sofiane, Buchert, Ralph, Brenner, Winfried, Munz, Dieter Ludwig, Thiel, Eckhard, Korfel, Agnieszka, Kiewe, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Versita, Warsaw 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691084/
https://www.ncbi.nlm.nih.gov/pubmed/23801905
http://dx.doi.org/10.2478/raon-2013-0016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691084/
https://www.ncbi.nlm.nih.gov/pubmed/23801905
http://dx.doi.org/10.2478/raon-2013-0016

Ejemplares similares